Researchers led by those at the University of Rochester, US, found that immune cells in the brain, known as microglia, act ...
A new, high-performance brain-computer interface (BCI) can be rapidly implanted through a minimally invasive procedure. The ...
Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...
An experimental drug called NU-9 has shown promise as an early intervention for Alzheimer's disease. | Drug Discovery And ...
We can replace joints, lenses, even organs—but not the brain. As neuroscience unravels the mechanisms of neurodegeneration, ...
Scientists are increasingly convinced that what happens in the mouth does not stay in the mouth. A growing body of research ...
UCI’s $12M CIRM award for hNSC-01 marks a pivotal shift to clinical-stage development. See how this state-funded "bridge" is ...
Experiments conducted in genetically engineered mice reinforce that CSE protein (ordinarily known for producing hydrogen ...
More than 7 million Americans have Alzheimer's disease, and two-thirds of them are women, according to the Alzheimer's ...
More than seven million Americans have Alzheimer's disease, and two-thirds of them are women, according to the Alzheimer's Association. The O'Banion Lab at the Del Monte Institute for Neuroscience at ...
Activating two somatostatin receptors enhances amyloid beta breakdown and improves memory in models of Alzheimer’s disease. Scientists at Karolinska Institutet in Sweden and the RIKEN Center for Brain ...